Literature DB >> 2117072

Increased virulence of a mouse-adapted variant of influenza A/FM/1/47 virus is controlled by mutations in genome segments 4, 5, 7, and 8.

E G Brown1.   

Abstract

To cause disease, influenza virus must possess several genetically determined abilities that mediate stages in pathogenesis. The virulent mouse-adapted variant A/FM/1/47-MA (FM-MA), derived from the avirulent A/FM/1/47 (FM) strain, had acquired mutations in genes that control virulence. The purpose of this study was to identify those genes that had mutated to result in increased virulence and to obtain viruses that differed in virulence because of differences in individual genome segments. The genes that had mutated to increase virulence were initially identified by genetic analysis of reassortants obtained by crossing FM-MA with the avirulent strain A/HK/1/68 (HK). FM-MA genome segments 4, 5, 7, and 8 were significantly associated with virulence, as determined by using the Wilcoxon ranked sum analysis. The role of FM-MA segments 4, 7, and 8 was confirmed by reintroduction of these genes into the parental strain, which also provided virus strains that differed in virulence because of mutations in individual genome segments. Segments 4, 7, and 8 were responsible for a 10(3.6)-fold increase in virulence that was proportioned 10(2.2)-, 10(0.7)-, and 10(0.8)-fold, respectively. The role of segment 5 could not be confirmed on transfer back into the parental strain because of reversion during preparation of such reassortants. The incidence of reversion was shown to be significantly associated with culturing of FM-MA in chicken embryo cells but was not associated with growth in MDCK cells. The genetic analysis of FM-MA suggests that adaptation to increased virulence is an incremental process that involves the acquisition of mutations in multiple genes, each of which plays an individual role in pathogenesis. The structural and functional properties of segments 4, 7, and 8 that control the virulence of FM-MA can now be determined by using viruses that differ in virulence because of mutations in these individual genome segments.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2117072      PMCID: PMC247923     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  35 in total

1.  Adaptation of influenza virus to mice. II. Changes in the growth curve of an A prime strain of influenza virus.

Authors:  B A BRIODY; W A CASSEL
Journal:  J Immunol       Date:  1955-01       Impact factor: 5.422

Review 2.  Molecular basis of infectivity and pathogenicity of myxovirus. Brief review.

Authors:  R Rott
Journal:  Arch Virol       Date:  1979       Impact factor: 2.574

3.  Correlation of pathogenicity and gene constellation of influenza A viruses. II. Highly neurovirulent recombinants derived from non-neurovirulent or weakly neurovirulent parent virus strains.

Authors:  C Scholtissek; A Vallbracht; B Flehmig; R Rott
Journal:  Virology       Date:  1979-06       Impact factor: 3.616

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The pathogenesis of infections of the mouse caused by virulent and avirulent variants of an influenza virus.

Authors:  S Raut; J Hurd; G Blandford; R B Heath; R J Cureton
Journal:  J Med Microbiol       Date:  1975-02       Impact factor: 2.472

6.  Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins.

Authors:  R A Lamb; C J Lai; P W Choppin
Journal:  Proc Natl Acad Sci U S A       Date:  1981-07       Impact factor: 11.205

7.  Neurovirulence of influenza virus in mice. I. Neurovirulence of recombinants between virulent and avirulent virus strains.

Authors:  A Sugiura; M Ueda
Journal:  Virology       Date:  1980-03       Impact factor: 3.616

8.  Neurovirulence of influenza virus in mice. II. Mechanism of virulence as studied in a neuroblastoma cell line.

Authors:  S Nakajima; A Sugiura
Journal:  Virology       Date:  1980-03       Impact factor: 3.616

9.  Correlation of pathogenicity and gene constellation of influenza A viruses. III. Non-pathogenic recombinants derived from highly pathogenic parent strains.

Authors:  R Rott; M Orlich; C Scholtissek
Journal:  J Gen Virol       Date:  1979-08       Impact factor: 3.891

10.  Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1.

Authors:  J F Young; U Desselberger; P Palese
Journal:  Cell       Date:  1979-09       Impact factor: 41.582

View more
  49 in total

1.  Suppression of influenza A virus replication in human lung epithelial cells by noncytotoxic concentrations bafilomycin A1.

Authors:  Behzad Yeganeh; Saeid Ghavami; Andrea L Kroeker; Thomas H Mahood; Gerald L Stelmack; Thomas Klonisch; Kevin M Coombs; Andrew J Halayko
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-10-31       Impact factor: 5.464

2.  Quantitative proteomic analyses of influenza virus-infected cultured human lung cells.

Authors:  Kevin M Coombs; Alicia Berard; Wanhong Xu; Oleg Krokhin; Xiaobo Meng; John P Cortens; Darwyn Kobasa; John Wilkins; Earl G Brown
Journal:  J Virol       Date:  2010-08-11       Impact factor: 5.103

3.  Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury.

Authors:  Risa Nakamura; Naoyoshi Maeda; Kensuke Shibata; Hisakata Yamada; Tetsuo Kase; Yasunobu Yoshikai
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

Review 4.  H5N1 vaccines in humans.

Authors:  Mariana Baz; Catherine J Luke; Xing Cheng; Hong Jin; Kanta Subbarao
Journal:  Virus Res       Date:  2013-05-28       Impact factor: 3.303

5.  Episodic evolution mediates interspecies transfer of a murine coronavirus.

Authors:  R S Baric; B Yount; L Hensley; S A Peel; W Chen
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 6.  Virulence of influenza A virus for mouse lung.

Authors:  A C Ward
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

7.  Experimental evolution of human influenza virus H3 hemagglutinin in the mouse lung identifies adaptive regions in HA1 and HA2.

Authors:  Liya Keleta; Aida Ibricevic; Nicolai V Bovin; Steven L Brody; Earl G Brown
Journal:  J Virol       Date:  2008-10-01       Impact factor: 5.103

8.  DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice.

Authors:  S Kodihalli; H Goto; D L Kobasa; S Krauss; Y Kawaoka; R G Webster
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

9.  Treating viral exacerbations of chronic obstructive pulmonary disease: insights from a mouse model of cigarette smoke and H1N1 influenza infection.

Authors:  Carla M T Bauer; Caleb C J Zavitz; Fernando M Botelho; Kristen N Lambert; Earl G Brown; Karen L Mossman; John D Taylor; Martin R Stämpfli
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

10.  Improved and simplified recombineering approach for influenza virus reverse genetics.

Authors:  Qinfang Liu; Shuai Wang; Guangpeng Ma; Juan Pu; Nicole E Forbes; Earl G Brown; Jin-Hua Liu
Journal:  J Mol Genet Med       Date:  2009-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.